Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does Cannabis Impair Cognitive Function in OSA? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

The use of cannabis in obstructive sleep apnoea (OSA)  raises concerns regarding cannabis and cognitive function. Patients may experience changes in attention, memory, and executive function, making it essential to understand potential impacts. 

Am I eligible for medical cannabis for pain relief?

Cognitive Risks with Cannabis 

Studies suggest that with cannabis, cognitive function can be affected in OSA patients, particularly with regular or high-dose use. Sleep disruption from OSA may compound these effects, increasing the likelihood of noticeable cognitive deficits. 

Memory Effects 

Patients may experience memory with cannabis in OSA issues, including short-term memory lapses and difficulties recalling information, which can affect daily functioning. 

Attention and Executive Function 

Impairments in focus, decision-making, and problem-solving can occur, representing a broader concern for cognition impairment with THC in OSA patients. 

Mitigation Strategies 

Monitoring cannabis use and adjusting dosage can help minimise negative impacts of cannabis on cognitive function. Clinicians should educate patients on risks, assess cognitive performance, and provide guidance for safer use. 

Understanding cannabis and cognitive function is crucial for managing OSA patients using cannabis. Awareness of memory and cannabis in OSA and cognition impairment with THC ensures patients can benefit from therapy while reducing potential cognitive drawbacks. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories